Journal of Neuro-Oncology

, Volume 145, Issue 3, pp 551–559 | Cite as

Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases

  • Christian Iorio-Morin
  • Rosalie Mercure-Cyr
  • Gabrielle Figueiredo
  • Charles Jean Touchette
  • Laurence Masson-Côté
  • David MathieuEmail author
Clinical Study



Stereotactic radiosurgery (SRS) is a well-established treatment option for brain metastases (BM). Repeat SRS for progressive BM is an increasingly used paradigm, although little data is available to support this practice. The goal of this study was to assess the safety and efficacy of a second SRS procedure on a previously treated BM.


We performed a retrospective metastasis-level analysis of patients who underwent two SRS procedures on the same lesion and for whom at least 6 months of radiological follow-up was available. The data collected included patient characteristics, clinical symptoms at time of treatment, SRS parameters, radiological response per RANO-BM criteria, clinical evolution and survival.


Seventy-five BM in 56 patients were included in the analysis. Most frequent primary histologies were non-small-cell lung cancer (59%) and breast cancer (19%). At the second SRS, median treatment volume was 1.19 cc (range 0.07–20.6) treated with a median margin dose of 18 Gy (range 12–20) at the 50% isodose line (range 30–80%). Median follow-up was 11 months. Progression per RANO-BM criteria occurred in 31%, yielding actuarial local control at 1, 2, and 5 years of 68%, 54% and 54% respectively. At last follow-up, 10 patients (18%) had improved relative to the initial presentation, while 21 (38%) were stable and 25 (44%) were deteriorated. Radiation-induced edema and radionecrosis occurred in 8.3% and 5% respectively. The median survival from the diagnosis of BM was 30 months.


Repeat SRS is a safe and effective novel therapeutic approach to consider in carefully selected patients.


Brain metastases Local recurrence Repeat treatment Stereotactic radiosurgery 




Compliance with ethical standards

Conflict of interest

The authors have no conflict of interest to report.

Supplementary material

11060_2019_3323_MOESM1_ESM.pdf (251 kb)
Supplementary material 1 (PDF 252 kb)


  1. 1.
    Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672. CrossRefPubMedGoogle Scholar
  2. 2.
    Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491. CrossRefPubMedGoogle Scholar
  3. 3.
    Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044. CrossRefPubMedGoogle Scholar
  4. 4.
    Brown PD, Ballman KV, Cerhan JH et al (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1049–1060. CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ammirati M, Cobbs CS, Linskey ME et al (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:85–96. CrossRefPubMedGoogle Scholar
  6. 6.
    Hong CS, Deng D, Vera A, Chiang VL (2019) Laser-interstitial thermal therapy compared to craniotomy for treatment of radiation necrosis or recurrent tumor in brain metastases failing radiosurgery. J Neurooncol 142:309–317. CrossRefPubMedGoogle Scholar
  7. 7.
    Terakedis BE, Jensen RL, Boucher K, Shrieve DC (2014) Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases. J Radiosurg SBRT 3:21–28PubMedPubMedCentralGoogle Scholar
  8. 8.
    Jayachandran P, Shultz D, Modlin L et al (2014) Repeat stereotactic radiosurgery (SRS) for brain metastases locally recurrent following initial SRS. Int J Radiat Oncol Biol Phys 90:S320. CrossRefGoogle Scholar
  9. 9.
    Trifiletti DM, Patel NV, Sheehan JP (2015) Repeated stereotactic radiosurgery for intracranial metastases after local failure: the safety and efficacy of repeat radiosurgery. Int J Radiat Oncol Biol Phys 93:E73. CrossRefGoogle Scholar
  10. 10.
    Minniti G, Scaringi C, Paolini S et al (2016) Repeated stereotactic radiosurgery for patients with progressive brain metastases. J Neurooncol 126:91–97. CrossRefPubMedGoogle Scholar
  11. 11.
    Koffer P, Chan J, Rava P et al (2017) Repeat stereotactic radiosurgery for locally recurrent brain metastases. World Neurosurg 104:589–593. CrossRefPubMedGoogle Scholar
  12. 12.
    McKay WH, McTyre ER, Okoukoni C et al (2017) Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg 127:148–156. CrossRefPubMedGoogle Scholar
  13. 13.
    Moreau J, Khalil T, Dupic G et al (2018) Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy. PLoS ONE 13:e0195608. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lin NU, Lee EQ, Aoyama H et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16:e270–e278. CrossRefPubMedGoogle Scholar
  15. 15.
    Solberg TD, Balter JM, Benedict SH et al (2012) Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: executive summary. Pract Radiat Oncol 2:2–9. CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Soon YY, Tham IWK, Lim KH et al (2014) Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases. Cochrane Database Syst Rev 295:CD009454. CrossRefGoogle Scholar
  17. 17.
    Brown PD, Jaeckle K, Ballman KV et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316:401–409. CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Iorio-Morin C, Masson-Côté L, Ezahr Y et al (2014) Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control. J Neurosurg 121(Suppl 2):69–74. CrossRefPubMedGoogle Scholar
  19. 19.
    Yamamoto M, Serizawa T, Shuto T et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387–395. CrossRefPubMedGoogle Scholar
  20. 20.
    Lucas JT, Colmer HG, White L et al (2015) Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases? Int J Radiat Oncol Biol Phys 92:1008–1015. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Shehata WM, Hendrickson FR, Hindo WA (1974) Rapid fractionation technique and re-treatment of cerebral metastases by irradiation. Cancer 34:257–261CrossRefGoogle Scholar
  22. 22.
    Iorio-Morin C, Liscak R, Vladyka V et al (2018) Repeat stereotactic radiosurgery for progressive or recurrent vestibular schwannomas. Neurosurgery 19:v1. CrossRefGoogle Scholar
  23. 23.
    Cohen-Inbar O, Tata A, Moosa S et al (2018) Stereotactic radiosurgery in the treatment of parasellar meningiomas: long-term volumetric evaluation. J Neurosurg 128:362–372. CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Neurosurgery, Department of SurgeryUniversité de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de SherbrookeSherbrookeCanada
  2. 2.Department of RadiologyUniversité de SherbrookeSherbrookeCanada
  3. 3.Department of Radiation OncologyUniversité de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de SherbrookeSherbrookeCanada

Personalised recommendations